In MDA-MB-231 cell line and human lymphatic endothelial cells, fucoxanthin inhibits tumour-related lymphangiogenesis, decreasing levels of VEGF-C, VEGF receptor-3, NF-κB, phospho-Akt and phospho-PI3K [206]. The gene discussed is NFKB1; the disease is neoplasm.